Print（PDF/196KB） Mar. 02, 2023 Corporate
Sumitomo Pharma Announces Organizational Realignment and Changes in the Positions Assumed by Executive Officers and Other Key Positions
Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following organizational realignment and changes in the positions assumed by Executive Officers and other key positions, effective April 1, 2023.
I. Organizational Realignment (effective April 1, 2023)
Corporate Departments
1. Business Development & Management is created by integrating Global Business Development and International Business Management.
2. Medical Science is created by integrating Medical Information, Medical Affairs, and a part of Oncology Clinical Development Unit.
3. Oncology Clinical Development Unit is dissolved and its functions are transferred to Drug Development Division and Medical Science.
4. Cancer Research Unit and Modality Research Unit are transferred to under Drug Research Division.
2. Medical Science is created by integrating Medical Information, Medical Affairs, and a part of Oncology Clinical Development Unit.
3. Oncology Clinical Development Unit is dissolved and its functions are transferred to Drug Development Division and Medical Science.
4. Cancer Research Unit and Modality Research Unit are transferred to under Drug Research Division.
II. Changes in the Positions Assumed by Executive Officers (effective April 1, 2023)
| Position as of April 1, 2023 | Current position | Name |
|---|---|---|
| Representative Director, Executive Vice President Global Corporate Strategy; Finance & Accounting; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant |
Representative Director, Executive Vice President Global Corporate Strategy; Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant |
Toru Kimura |
| Member, Board of Directors, Senior Executive Officer Drug Research Division Head of Japan Business Unit |
Member, Board of Directors, Senior Executive Officer Cancer Research; Modality Research; Drug Research Division Head of Japan Business Unit |
Yoshiharu Ikeda |
| Member, Board of Directors, Senior Executive Officer Business Development & Management |
Member, Board of Directors, Senior Executive Officer Global Business Development; International Business Management |
Shigeyuki Nishinaka |
| Executive Officer Regulatory Affairs; Medical Science; Corporate Regulatory Compliance & Quality Assurance Executive Director, Corporate Regulatory Compliance & Quality Assurance Division Deputy Head of Japan Business Unit |
Executive Officer Regulatory Affairs; Medical Information; Medical Affairs; Corporate Regulatory Compliance & Quality Assurance Executive Director, Corporate Regulatory Compliance & Quality Assurance Division Deputy Head of Japan Business Unit |
Koichi Kozuki |
| Executive Officer Corporate Governance; Corporate Communications Senior Director, Corporate Communications |
Executive Officer Corporate Governance; Corporate Communications Senior Director, Corporate Governance |
Naoki Noguchi |
| Executive Officer Executive Vice President, Sumitomo Pharma America Holdings, Inc. |
Executive Officer Senior Director, Global Corporate Strategy |
Tsutomu Nakagawa |
III. Changes in Personnel (effective April 1, 2023)
Corporate Departments
| Position as of April 1, 2023 | Current position | Name |
|---|---|---|
| Senior Director, Global Corporate Strategy |
Director, Corporate Planning Group, Global Corporate Strategy | Yutaka Wakemi |
| Senior Director, Special Missions for North America Business | Senior Director, International Business Management | Tatsuya Ito |
| Senior Director, Business Development & Management | Senior Director, Global Business Development | Katsumi Tanaka |
| Senior Director, Regulatory Affairs | Director, RA Group, Regulatory Affairs | Masatsugu Kobayashi |
| Senior Director, Corporate Governance |
Senior Director, Corporate Secretariat | Koichi Kino |
| Senior Director, Corporate Secretariat | Director, R&D Strategy Group, Global Corporate Strategy | Kotaro Hirota |
| Senior Director, IT Management & Digital Transformation | Director, IT Management Group, IT Management & Digital Transformation | Nobuaki Doi |
| Senior Director, Medical Science | Senior Director, Medical Information | Keiko Hirano |
| Senior Vice President, Corporate Management; Finance; Compliance; Internal Control Sumitomo Pharma (China) Co., Ltd. Senior Vice President, Sumitomo Pharma (Suzhou) Co., Ltd. |
Director, Labor Relations Group, Human Resources | Toru Yamashita |
| Senior Vice President, Head of Commercial Division, Sumitomo Pharma (Suzhou) Co., Ltd. Senior Vice President, Sumitomo Pharma (China) Co., Ltd. |
Director, Planning & Marketing Group, Sales & Marketing Management | Ryosuke Mori |
Corporate Regulatory Compliance & Quality Assurance (Division)
| Position as of April 1, 2023 | Current position | Name |
|---|---|---|
| Senior Director, Quality Management |
Deputy Senior Director, Quality Assurance, Oita Plant |
Shuji Yamaguchi |
Drug Research (Division)
| Position as of April 1, 2023 | Current position | Name |
|---|---|---|
| Senior Research Project Director, Cancer Research, Drug Research Division |
Senior Director, Cancer Research Unit Director, Research Planning Group, Cancer Research Unit |
Setsuko Yamamoto |
| Senior Director, External Innovation | Project Leader, Fellow, Kitasato-Sumitomo Collaboration External Innovation |
Jun Hidaka |
| Senior Director, Modality Research Unit Senior Director, Cancer Research Unit |
Senior Director, Modality Research Unit Senior Project Director, Drug Research, Drug Research Division |
Hitoshi Ban |
Drug Development (Division)
| Position as of April 1, 2023 | Current position | Name |
|---|---|---|
| Senior Director, Clinical Operation | Director, Project Management Group, Development Planning & Management | Taiji Ono |
Sales & Marketing (Division)
| Position as of April 1, 2023 | Current position | Name |
|---|---|---|
| Senior Director, Sales & Marketing Management Senior Director, MarTech Strategy Office |
Senior Director, Sales & Marketing Management | Yasutoshi Araki |
| Senior Director, Yokohama Branch | Senior Vice President, Head of Commercial Division, Sumitomo Pharma (Suzhou) Co., Ltd. Senior Vice President, Sumitomo Pharma (China) Co., Ltd. |
Yasuhiro Kami |
Manufacturing (Division)
| Position as of April 1, 2023 | Current position | Name |
|---|---|---|
| Executive Director, Manufacturing Division Deputy Head of Japan Business Unit |
Senior Director, Manufacturing Management | Kimihiro Mizuno |
| Senior Director, Manufacturing Management | Senior Director, Suzuka Plant | Mitsuhito Kondo |
| Senior Director, Suzuka Plant | Deputy Senior Director, Administration, Suzuka Plant | Kazuyuki Fujihara |
| Deputy Senior Director, Administration, Suzuka Plant | Director, Strategic Supply Chain Planning Group, Manufacturing Management | Tetsuya Yamaji |
| Deputy Senior Director, Quality Assurance, Suzuka Plant | Senior Vice President, Head of Production Division, Sumitomo Pharma (Suzhou) Co., Ltd. Senior Vice President, Sumitomo Pharma (China) Co., Ltd. |
Takahiro Jikihara |
| Deputy Senior Director, Engineering, Suzuka Plant | Manufacturing Innovation Officer, Suzuka Plant | Satoshi Nagano |
| Senior Director, Oita Plant | Deputy Senior Director, Quality Assurance, Suzuka Plant | Toyohiro Nishikawa |
| Deputy Senior Director, Quality Assurance, Oita Plant | Director, Formulation Section, Manufacturing, Oita Plant | Toshiyuki Hosokawa |
Inquiries from the Press